Clark Capital Management Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Clark Capital Management Group’s Portfolio XPH Stock Details XPH Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.25M	Buy
2022 Q3	–	Sell
2022 Q2	$4.71M	Buy
2020 Q1	–	Sell
2019 Q4	$1.88M	Buy